Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Rose Bio Solutions Appoints David Enloe As Chief Executive Officer

PRIVATESep 08, 2026•about 3 hours ago

Position

Chief Executive Officer

Company

Rose BioSolutions

David Enloe
RockvilleManufacturingBiotechnology

Description

Rose Bio announced the appointment of David Enloe as Chief Executive Officer, bringing over 35 years of experience in biotech and pharma services. His leadership is expected to advance Rose Bio's mission in the cell and gene therapy industry.

Company Information

Company

Rose BioSolutions

Location

Rockville, Maryland, United States

About

Rose BioSolutions is a leading provider of development and advanced manufacturing capabilities across the cell and gene therapy space. As a full-service CDMO, Rose Bio is purpose-built to deliver end-to-end solutions for clients on industry-leading timelines. The company offers manufacturing across the full suite of plasmid DNA, viral vector, and cell therapies, as well as cell supply operations.

Don't miss Rose BioSolutions's next move

Get an email the moment Rose BioSolutions changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Rose BioSolutions's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Rose BioSolutions changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.